Spiracur raises $35mm in third round
In what appears to be its third round, Spiracur Inc. (developing a portable negative pressure wound therapy device) has raised $35mm. New investor Maverick Capital led (and takes a seat on the company's board) and was joined by Pinnacle Ventures and returning backers De Novo Ventures, Kleiner Perkins Caufield & Byers, and New Leaf Venture Partners. Spiracur's last-announced fundraising was a $20.3mm Series B round in July 2009.
- Medical Devices
- Venture Financing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com